使无罪 发表于 2025-3-21 16:14:29

书目名称Renal Cell Carcinoma影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0826987<br><br>        <br><br>书目名称Renal Cell Carcinoma读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0826987<br><br>        <br><br>

我怕被刺穿 发表于 2025-3-21 23:50:51

http://reply.papertrans.cn/83/8270/826987/826987_2.png

Melatonin 发表于 2025-3-22 01:39:17

Molecular Genetics of Renal Cell Carcinoma,and whole-genome sequencing, the genomic landscapes of renal cell carcinoma (RCC), consisting mainly of clear-cell, papillary (1 and 2), and chromophobe subtypes, have been characterized. This genomic information, coupled with DNA methylation, has shed light on the molecular biology of RCC and creat

Ptsd429 发表于 2025-3-22 04:41:15

http://reply.papertrans.cn/83/8270/826987/826987_4.png

预防注射 发表于 2025-3-22 10:42:12

Imaging Features of Renal Cell Carcinoma Differential Diagnosis, Staging, and Posttreatment Evaluatection of various subtypes of renal cell carcinomas (RCCs) and benign renal tumors. The differentiation of RCCs from benign tumors such as fat-poor angiomyolipoma and oncocytoma is very important to prevent unnecessary surgery. In addition, the recent progress of therapies to treat RCCs, including n

Fester 发表于 2025-3-22 14:29:56

http://reply.papertrans.cn/83/8270/826987/826987_6.png

外观 发表于 2025-3-22 19:55:59

Natural History and Active Surveillance,is seen in cancers less than 4 cm. Surgery, either radical or partial nephrectomy, has been the mainstay of treatment of a small renal mass (SRM), defined as a usually incidentally discovered renal mass <4 cm in diameter which enhances on contrast imaging. There is morbidity associated with this sta

和平主义者 发表于 2025-3-23 00:27:23

Surgical Treatment for Renal Cell Carcinoma,f renal cell carcinoma is an integral component of oncologic management. The spectrum of renal cell carcinoma presentation from small renal masses, locally advanced disease, and in the presence of metastasis varies with the surgical armamentarium needed to treat this diverse group of patients. In ge

GROG 发表于 2025-3-23 02:37:13

http://reply.papertrans.cn/83/8270/826987/826987_9.png

废墟 发表于 2025-3-23 08:33:12

Tyrosine Kinase Inhibitors: Sorafenib, Sunitinib, Axitinib, and Pazopanib,ant improvement in patient outcomes. To date, targeting the vascular endothelial growth factor receptor (VEGFR) has been shown to lead to improved clinical outcomes in metastatic RCC. Currently, four VEGFR tyrosine kinase inhibitors (TKIs) have been approved by the Food and Drug Administration (FDA)
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: Renal Cell Carcinoma; Molecular Features a Mototsugu Oya Book 2017 Springer Japan KK 2017 Molecular-targeted therapy.TKI.anti-angiogenic ag